Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.13
PDCO's Cash to Debt is ranked lower than
84% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.65 vs. PDCO: 0.13 )
Ranked among companies with meaningful Cash to Debt only.
PDCO' s Cash to Debt Range Over the Past 10 Years
Min: 0.13  Med: 0.74 Max: No Debt
Current: 0.13
Equity to Asset 0.41
PDCO's Equity to Asset is ranked higher than
53% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. PDCO: 0.41 )
Ranked among companies with meaningful Equity to Asset only.
PDCO' s Equity to Asset Range Over the Past 10 Years
Min: 0.41  Med: 0.61 Max: 0.77
Current: 0.41
0.41
0.77
Interest Coverage 6.95
PDCO's Interest Coverage is ranked lower than
53% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.55 vs. PDCO: 6.95 )
Ranked among companies with meaningful Interest Coverage only.
PDCO' s Interest Coverage Range Over the Past 10 Years
Min: 6.95  Med: 11.64 Max: 28.08
Current: 6.95
6.95
28.08
F-Score: 4
Z-Score: 4.19
M-Score: -2.12
WACC vs ROIC
7.87%
8.79%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.46
PDCO's Operating margin (%) is ranked higher than
65% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.04 vs. PDCO: 6.46 )
Ranked among companies with meaningful Operating margin (%) only.
PDCO' s Operating margin (%) Range Over the Past 10 Years
Min: 6.46  Med: 10.55 Max: 12
Current: 6.46
6.46
12
Net-margin (%) 3.47
PDCO's Net-margin (%) is ranked higher than
67% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. PDCO: 3.47 )
Ranked among companies with meaningful Net-margin (%) only.
PDCO' s Net-margin (%) Range Over the Past 10 Years
Min: 3.47  Med: 6.24 Max: 7.5
Current: 3.47
3.47
7.5
ROE (%) 13.01
PDCO's ROE (%) is ranked higher than
73% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.54 vs. PDCO: 13.01 )
Ranked among companies with meaningful ROE (%) only.
PDCO' s ROE (%) Range Over the Past 10 Years
Min: 12.67  Med: 15.10 Max: 18.86
Current: 13.01
12.67
18.86
ROA (%) 5.28
PDCO's ROA (%) is ranked higher than
78% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.70 vs. PDCO: 5.28 )
Ranked among companies with meaningful ROA (%) only.
PDCO' s ROA (%) Range Over the Past 10 Years
Min: 5.79  Med: 8.53 Max: 11.2
Current: 5.28
5.79
11.2
ROC (Joel Greenblatt) (%) 32.75
PDCO's ROC (Joel Greenblatt) (%) is ranked higher than
73% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.70 vs. PDCO: 32.75 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PDCO' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 36.84  Med: 58.52 Max: 78.86
Current: 32.75
36.84
78.86
Revenue Growth (3Y)(%) 16.20
PDCO's Revenue Growth (3Y)(%) is ranked higher than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.50 vs. PDCO: 16.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PDCO' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 6.9  Med: 12.40 Max: 18.9
Current: 16.2
6.9
18.9
EBITDA Growth (3Y)(%) 4.50
PDCO's EBITDA Growth (3Y)(%) is ranked lower than
56% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.70 vs. PDCO: 4.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PDCO' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 3.3  Med: 8.10 Max: 25.9
Current: 4.5
3.3
25.9
EPS Growth (3Y)(%) -2.20
PDCO's EPS Growth (3Y)(%) is ranked lower than
85% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.90 vs. PDCO: -2.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PDCO' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.2  Med: 8.60 Max: 24.3
Current: -2.2
-2.2
24.3
» PDCO's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-27)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

PDCO Guru Trades in Q3 2015

Ray Dalio 9,902 sh (New)
John Hussman 150,000 sh (+200.00%)
Robert Olstein 245,000 sh (+18.93%)
Tom Gayner 168,000 sh (+0.60%)
Third Avenue Management 145,133 sh (unchged)
First Pacific Advisors Sold Out
Joel Greenblatt Sold Out
Jeremy Grantham 53,500 sh (-0.93%)
Mairs and Power 1,397,229 sh (-3.35%)
Mario Gabelli 1,699,613 sh (-8.24%)
Paul Tudor Jones 15,200 sh (-24.75%)
Jim Simons 33,304 sh (-87.39%)
» More
Q4 2015

PDCO Guru Trades in Q4 2015

Tom Gayner 168,000 sh (unchged)
Jim Simons Sold Out
Ray Dalio Sold Out
John Hussman Sold Out
Mario Gabelli 1,696,428 sh (-0.19%)
Mairs and Power 1,386,294 sh (-0.78%)
Robert Olstein 230,000 sh (-6.12%)
Jeremy Grantham 48,700 sh (-8.97%)
Paul Tudor Jones 12,100 sh (-20.39%)
Third Avenue Management 109,335 sh (-24.67%)
» More
Q1 2016

PDCO Guru Trades in Q1 2016

Robert Olstein 254,700 sh (+10.74%)
Tom Gayner 168,000 sh (unchged)
Third Avenue Management 109,335 sh (unchged)
Jeremy Grantham Sold Out
Mairs and Power 1,380,227 sh (-0.44%)
Mario Gabelli 1,605,561 sh (-5.36%)
Paul Tudor Jones 9,300 sh (-23.14%)
» More
Q2 2016

PDCO Guru Trades in Q2 2016

Jerome Dodson 440,000 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with PDCO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:OTCPK:SHPMF, OTCPK:MAHLY, NYSE:PBH, NYSE:OMI, OTCPK:UDHCF, NYSE:PMC, OTCPK:SNYR, OTCPK:ANNIF, OTCPK:SCVM, OTCPK:FZMD, OTCPK:NPHC, OTCPK:SHTDF, NAS:HSIC, NYSE:ABC, NYSE:CAH, NYSE:MCK » details
Traded in other countries:PD2.Germany,
Patterson Companies Inc is a distributors of dental products in North America. The Company operates in three business segments: dental supply, veterinary supply and rehabilitation supply.

Patterson Companies Inc is a distributor of dental supply in North America, companion animal and equine veterinary supply in USA and rehabilitation and assistive products supply. Its dental business has operations in the United States and Canada. Patterson Dental is a full-service supplier to dentists, dental laboratories, institutions, and other healthcare professionals, provides consumable products (including x-ray film, restorative materials, hand instruments and sterilization products); basic and advanced technology dental equipment; practice management and clinical software; patient education systems; and office forms and stationery. Patterson Dental also offers customers related services including dental equipment installation, maintenance and repair, dental office design and equipment financing. It markets its dental products and services through more than 1,500 direct sales representatives, of which approximately 300 are equipment specialists. Its veterinary supply business is a distributor of veterinary supplies to companion-pet (dogs, cats and other common household pets) and equine veterinary clinics across the United States. Patterson Veterinary provides products and services used for the diagnosis, treatment and/or prevention of diseases in companion animals and equine. Its Rehabilitation Supply supply business is a distributor of rehabilitation medical supplies and equipment. Patterson Medical offers distributed and self-manufactured rehabilitation products to health care professionals. The Company's products and services are sold under numerous trademarks including PATTERSON, EAGLESOFT, CAESY, SAMMONS PRESTON, KINETEC, TUMBLE FORMS, INTRAVET, and DIA. The Company is subject to regulation by the Federal Food and Drug Administration, the Drug Enforcement Administration and the U.S. Department of Transportation.

Top Ranked Articles about Patterson Companies Inc

Jerome Dodson Goes 3 for 3 in Second Quarter Dodson gains 3 new holdings, sells 3
Investor Jerome Dodson (Trades, Portfolio) of the Parnassus Fund gained three new holdings and sold out three holdings during the second quarter. Read more...
Jerome Dodson Purchases Shares of Patterson Companies Patterson Companies has reported solid revenue per share growth over the previous 10 years
During the second quarter, Jerome Dodson (Trades, Portfolio) purchased a 440,000-share stake in Patterson Companies Inc. The trade had a 3.08% impact on Dodson’s portfolio. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 25.63
PDCO's P/E(ttm) is ranked lower than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.99 vs. PDCO: 25.63 )
Ranked among companies with meaningful P/E(ttm) only.
PDCO' s P/E(ttm) Range Over the Past 10 Years
Min: 9.51  Med: 19.74 Max: 33.28
Current: 25.63
9.51
33.28
Forward P/E 17.27
PDCO's Forward P/E is ranked lower than
58% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.56 vs. PDCO: 17.27 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 25.90
PDCO's PE(NRI) is ranked lower than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.99 vs. PDCO: 25.90 )
Ranked among companies with meaningful PE(NRI) only.
PDCO' s PE(NRI) Range Over the Past 10 Years
Min: 9.51  Med: 20.08 Max: 33.28
Current: 25.9
9.51
33.28
Price/Owner Earnings (ttm) 35.02
PDCO's Price/Owner Earnings (ttm) is ranked lower than
67% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 24.11 vs. PDCO: 35.02 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
PDCO' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 12.42  Med: 23.22 Max: 68.98
Current: 35.02
12.42
68.98
P/B 3.39
PDCO's P/B is ranked lower than
72% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.24 vs. PDCO: 3.39 )
Ranked among companies with meaningful P/B only.
PDCO' s P/B Range Over the Past 10 Years
Min: 1.8  Med: 2.95 Max: 5.8
Current: 3.39
1.8
5.8
P/S 0.91
PDCO's P/S is ranked higher than
50% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.90 vs. PDCO: 0.91 )
Ranked among companies with meaningful P/S only.
PDCO' s P/S Range Over the Past 10 Years
Min: 0.65  Med: 1.12 Max: 2.54
Current: 0.91
0.65
2.54
PFCF 62.80
PDCO's PFCF is ranked lower than
95% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.00 vs. PDCO: 62.80 )
Ranked among companies with meaningful PFCF only.
PDCO' s PFCF Range Over the Past 10 Years
Min: 9.27  Med: 20.73 Max: 333.08
Current: 62.8
9.27
333.08
POCF 31.02
PDCO's POCF is ranked lower than
86% of the 22 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.27 vs. PDCO: 31.02 )
Ranked among companies with meaningful POCF only.
PDCO' s POCF Range Over the Past 10 Years
Min: 8.34  Med: 17.48 Max: 275.91
Current: 31.02
8.34
275.91
EV-to-EBIT 16.63
PDCO's EV-to-EBIT is ranked lower than
55% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.20 vs. PDCO: 16.63 )
Ranked among companies with meaningful EV-to-EBIT only.
PDCO' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.6  Med: 12.50 Max: 21.5
Current: 16.63
6.6
21.5
EV-to-EBITDA 13.39
PDCO's EV-to-EBITDA is ranked lower than
54% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.68 vs. PDCO: 13.39 )
Ranked among companies with meaningful EV-to-EBITDA only.
PDCO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.1  Med: 11.20 Max: 18.9
Current: 13.39
6.1
18.9
PEG 5.49
PDCO's PEG is ranked lower than
82% of the 22 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.23 vs. PDCO: 5.49 )
Ranked among companies with meaningful PEG only.
PDCO' s PEG Range Over the Past 10 Years
Min: 0.94  Med: 2.03 Max: 28.11
Current: 5.49
0.94
28.11
Shiller P/E 24.67
PDCO's Shiller P/E is ranked higher than
65% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.60 vs. PDCO: 24.67 )
Ranked among companies with meaningful Shiller P/E only.
PDCO' s Shiller P/E Range Over the Past 10 Years
Min: 13.79  Med: 21.85 Max: 43.36
Current: 24.67
13.79
43.36
Current Ratio 2.11
PDCO's Current Ratio is ranked higher than
69% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.58 vs. PDCO: 2.11 )
Ranked among companies with meaningful Current Ratio only.
PDCO' s Current Ratio Range Over the Past 10 Years
Min: 2.07  Med: 2.70 Max: 3.35
Current: 2.11
2.07
3.35
Quick Ratio 1.24
PDCO's Quick Ratio is ranked higher than
56% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.13 vs. PDCO: 1.24 )
Ranked among companies with meaningful Quick Ratio only.
PDCO' s Quick Ratio Range Over the Past 10 Years
Min: 1.24  Med: 1.99 Max: 2.61
Current: 1.24
1.24
2.61
Days Inventory 61.33
PDCO's Days Inventory is ranked lower than
62% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 48.45 vs. PDCO: 61.33 )
Ranked among companies with meaningful Days Inventory only.
PDCO' s Days Inventory Range Over the Past 10 Years
Min: 47.47  Med: 49.79 Max: 50.77
Current: 61.33
47.47
50.77
Days Sales Outstanding 53.98
PDCO's Days Sales Outstanding is ranked higher than
56% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 54.55 vs. PDCO: 53.98 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDCO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.31  Med: 49.31 Max: 56.17
Current: 53.98
44.31
56.17
Days Payable 50.86
PDCO's Days Payable is ranked lower than
66% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 69.49 vs. PDCO: 50.86 )
Ranked among companies with meaningful Days Payable only.
PDCO' s Days Payable Range Over the Past 10 Years
Min: 31.98  Med: 36.27 Max: 50.86
Current: 50.86
31.98
50.86

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.86
PDCO's Dividend Yield is ranked higher than
54% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.16 vs. PDCO: 1.86 )
Ranked among companies with meaningful Dividend Yield only.
PDCO' s Dividend Yield Range Over the Past 10 Years
Min: 0.31  Med: 1.55 Max: 2.19
Current: 1.86
0.31
2.19
Dividend Payout 0.47
PDCO's Dividend Payout is ranked higher than
70% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.29 vs. PDCO: 0.47 )
Ranked among companies with meaningful Dividend Payout only.
PDCO' s Dividend Payout Range Over the Past 10 Years
Min: 0.06  Med: 0.29 Max: 0.47
Current: 0.47
0.06
0.47
Dividend Growth (3y) 15.80
PDCO's Dividend Growth (3y) is ranked higher than
60% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.20 vs. PDCO: 15.80 )
Ranked among companies with meaningful Dividend Growth (3y) only.
PDCO' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 79.7
Current: 15.8
0
79.7
Forward Dividend Yield 1.94
PDCO's Forward Dividend Yield is ranked higher than
53% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.95 vs. PDCO: 1.94 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 4.04
PDCO's Yield on cost (5-Year) is ranked higher than
54% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.03 vs. PDCO: 4.04 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PDCO' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.68  Med: 3.38 Max: 4.78
Current: 4.04
0.68
4.78
3-Year Average Share Buyback Ratio 2.10
PDCO's 3-Year Average Share Buyback Ratio is ranked higher than
87% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.10 vs. PDCO: 2.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PDCO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.1  Med: 0.30 Max: 5.1
Current: 2.1
-1.1
5.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 42.32
PDCO's Price/Tangible Book is ranked lower than
100% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.35 vs. PDCO: 42.32 )
Ranked among companies with meaningful Price/Tangible Book only.
PDCO' s Price/Tangible Book Range Over the Past 10 Years
Min: 4.45  Med: 9.40 Max: 48.72
Current: 42.32
4.45
48.72
Price/Projected FCF 1.30
PDCO's Price/Projected FCF is ranked higher than
52% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.29 vs. PDCO: 1.30 )
Ranked among companies with meaningful Price/Projected FCF only.
PDCO' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.77  Med: 1.50 Max: 3.32
Current: 1.3
0.77
3.32
Price/DCF (Earnings Based) 2.42
PDCO's Price/DCF (Earnings Based) is ranked lower than
100% of the 9 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. PDCO: 2.42 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.81
PDCO's Price/Median PS Value is ranked higher than
77% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.00 vs. PDCO: 0.81 )
Ranked among companies with meaningful Price/Median PS Value only.
PDCO' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.7  Med: 1.15 Max: 2.59
Current: 0.81
0.7
2.59
Price/Graham Number 6.98
PDCO's Price/Graham Number is ranked lower than
96% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.01 vs. PDCO: 6.98 )
Ranked among companies with meaningful Price/Graham Number only.
PDCO' s Price/Graham Number Range Over the Past 10 Years
Min: 2.04  Med: 2.80 Max: 8.57
Current: 6.98
2.04
8.57
Earnings Yield (Greenblatt) (%) 6.11
PDCO's Earnings Yield (Greenblatt) (%) is ranked higher than
53% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. PDCO: 6.11 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PDCO' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.7  Med: 8.00 Max: 15.1
Current: 6.11
4.7
15.1
Forward Rate of Return (Yacktman) (%) 4.92
PDCO's Forward Rate of Return (Yacktman) (%) is ranked lower than
68% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. PDCO: 4.92 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
PDCO' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 3.1  Med: 11.90 Max: 27.2
Current: 4.92
3.1
27.2

More Statistics

Revenue (TTM) (Mil) $5,387
EPS (TTM) $ 1.93
Beta0.95
Short Percentage of Float6.36%
52-Week Range $38.51 - 53.07
Shares Outstanding (Mil)99.10

Analyst Estimate

Apr17 Apr18 Apr19
Revenue (Mil $) 5,961 6,271 6,729
EPS ($) 2.85 3.16 3.55
EPS w/o NRI ($) 2.85 3.16 3.55
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($) 0.96 1.03
» More Articles for PDCO

Headlines

Articles On GuruFocus.com
Jerome Dodson Goes 3 for 3 in Second Quarter Jul 21 2016 
Jerome Dodson Purchases Shares of Patterson Companies Inc Jul 20 2016 
Estimate for Patterson Companies' Intrinsic Value Equals the Market Price Mar 24 2015 
Mario Gabelli on Aging America, Alcohol, Twitter, Facebook Dec 17 2013 
Mario Gabelli’s Best Value Plays Nov 21 2012 
Owens & Minor Inc. (OMI) Dividend Stock Analysis Aug 03 2012 
The Best Dividends on April 9, 2012 Apr 06 2012 
Owens & Minor Inc. (OMI) Dividend Stock Analysis Sep 16 2011 
WEEKLY CFO SELLS HIGHLIGHT: KRA, CNK, VFC, BCR, PDCO Jun 25 2011 
Guru Stocks Raising Dividends: ADP, INDB, WASH, PDCO, ASH Mar 19 2011 

More From Other Websites
Former Target exec joins Patterson Cos. as CMO Jul 22 2016
Patterson Cos., Inc. :PDCO-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 Jul 22 2016
Todd Marshall Joins Patterson Companies as Chief Marketing and Digital Officer Jul 22 2016
Jerome Dodson Goes 3 for 3 in Second Quarter Jul 21 2016
Jerome Dodson Purchases Shares of Patterson Companies Inc Jul 20 2016
Patterson Cos., Inc. : PDCO-US: Dividend Analysis : July 15th, 2016 (record date) : By the numbers :... Jul 20 2016
Patterson Dental offers disaster relief to West Virginia customers Jul 07 2016
PATTERSON COMPANIES, INC. Financials Jul 06 2016
PATTERSON COMPANIES, INC. Files SEC form 10-K, Annual Report Jun 29 2016
Patterson Cos., Inc. breached its 50 day moving average in a Bearish Manner : PDCO-US : June 28,... Jun 28 2016
Patterson Cos., Inc. : PDCO-US: Dividend Analysis : July 15th, 2016 (record date) : By the numbers :... Jun 24 2016
PATTERSON COMPANIES, INC. Files SEC form 8-K, Other Events Jun 23 2016
Patterson Companies Declares Quarterly Dividend Jun 14 2016
The C-Suite Speaks: Strategic Directions Jun 10 2016
PATTERSON COMPANIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jun 02 2016
Patterson Companies Names Paul Guggenheim Chief Innovation Officer Jun 02 2016
Patterson Companies Announces Upcoming Investor Conference Schedule Jun 01 2016
Dental Stocks Keep Gleaming As Patterson Beats Q4 Earnings May 26 2016
Edited Transcript of PDCO earnings conference call or presentation 26-May-16 2:00pm GMT May 26 2016
PATTERSON COMPANIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 26 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)